XML 45 R34.htm IDEA: XBRL DOCUMENT v3.4.0.3
FAIR VALUE (Tables)
6 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on a Recurring and Nonrecurring Basis
Assets and liabilities measured at fair value on a recurring and nonrecurring basis are presented below:
March 31, 2016
 
Quoted prices
in active
markets for
identical
assets
(Level 1)
(1)
 
Significant
other
observable
inputs
(Level 2) (1)
 
Significant
unobservable
inputs
(Level 3)
 
Netting
adjustments (2)
 
Balance as of
March 31,
2016
 
 
(in thousands)
Assets at fair value on a recurring basis:
 
 
 
 
 
 
 
 
 
 
Trading instruments:
 
 
 
 
 
 
 
 
 
 
Municipal and provincial obligations
 
$
102

 
$
239,478

 
$
—

 
$
—

 
$
239,580

Corporate obligations
 
4,976

 
132,085

 
—

 
—

 
137,061

Government and agency obligations
 
7,897

 
125,590

 
—

 
—

 
133,487

Agency mortgage-backed securities (“MBS”) and collateralized mortgage obligations (“CMOs”)
 
433

 
98,144

 
—

 
—

 
98,577

Non-agency CMOs and asset-backed securities (“ABS”)
 
—

 
35,925

 
8

 
—

 
35,933

Total debt securities
 
13,408

 
631,222

 
8

 
—

 
644,638

Derivative contracts
 
—

 
147,905

 
—

 
(96,630
)
 
51,275

Equity securities
 
53,338

 
1,186

 
—

 
—

 
54,524

Brokered certificates of deposit
 
—

 
32,257

 
—

 
—

 
32,257

Other
 
534

 
1,929

 
14,296

 
—

 
16,759

Total trading instruments
 
67,280

 
814,499

 
14,304

 
(96,630
)
 
799,453

Available for sale securities:
 
 

 
 

 
 

 
 

 
 

Agency MBS and CMOs
 
—

 
354,430

 
—

 
—

 
354,430

Non-agency CMOs
 
—

 
63,694

 
—

 
—

 
63,694

Other securities
 
1,297

 
—

 
—

 
—

 
1,297

Auction rate securities (“ARS”):
 
 
 
 
 
 
 
 

 
 

Municipals
 
—

 
—

 
25,422

 
—

 
25,422

Preferred securities
 
—

 
—

 
102,599

 
—

 
102,599

Total available for sale securities
 
1,297

 
418,124

 
128,021

 
—

 
547,442

Private equity investments
 
—

 
—

 
204,398

(3) 
—

 
204,398

Other investments (4)
 
271,885

 
21,774

 
439

 
—

 
294,098

Derivative instruments associated with offsetting matched book positions
 
—

 
396,163

 
—

 
—

 
396,163

Deposits with clearing organizations:
 
 
 
 
 
 
 
 
 
 
Government and agency obligations
 
29,636

 
—

 
—

 
—

 
29,636

Other assets:
 
 
 
 
 
 
 
 
 
 
Derivative contracts (5)
 
—

 
2,938

 
—

 
—

 
2,938

Other assets
 
—

 
—

 
3,112

(6) 
—

 
3,112

Total other assets
 
—

 
2,938

 
3,112

 
—

 
6,050

Total assets at fair value on a recurring basis
 
$
370,098

 
$
1,653,498

 
$
350,274

 
$
(96,630
)
 
$
2,277,240

 
 
 
 
 
 
 
 
 
 
 
Assets at fair value on a nonrecurring basis:
 
 
 
 

 
 

 
 

 
 

Bank loans, net:
 
 

 
 

 
 

 
 

 
 

Impaired loans
 
$
—

 
$
26,228

 
$
35,720

 
$
—

 
$
61,948

Loans held for sale(7)
 
—

 
78,297

 
—

 
—

 
78,297

Total bank loans, net
 
—

 
104,525

 
35,720

 
—

 
140,245

Other real estate owned (“OREO”)(8)
 
—

 
238

 
—

 
—

 
238

Total assets at fair value on a nonrecurring basis
 
$
—

 
$
104,763

 
$
35,720

 
$
—

 
$
140,483

 
(continued on next page)
March 31, 2016
 
Quoted prices
in active
markets for
identical
assets
(Level 1) (1)
 
Significant
other
observable
inputs
(Level 2) (1)
 
Significant
unobservable
inputs
(Level 3)
 
Netting
adjustments (2)
 
Balance as of
March 31,
2016
 
 
(in thousands)
 
 
(continued from previous page)
Liabilities at fair value on a recurring basis:
 
 
 
 
 
 
 
 
 
 
Trading instruments sold but not yet purchased:
 
 
 
 
 
 
 
 
 
 
Municipal and provincial obligations
 
$
4

 
$
—

 
$
—

 
$
—

 
$
4

Corporate obligations
 
1,102

 
47,758

 
—

 
—

 
48,860

Government obligations
 
260,727

 
—

 
—

 
—

 
260,727

Agency MBS and CMOs
 
3,122

 
—

 
—

 
—

 
3,122

Total debt securities
 
264,955

 
47,758

 
—

 
—

 
312,713

Derivative contracts
 
—

 
135,641

 
—

 
(128,002
)
 
7,639

Equity securities
 
4,958

 
—

 
—

 
—

 
4,958

Other securities
 
—

 
100

 
—

 
—

 
100

Total trading instruments sold but not yet purchased
 
269,913

 
183,499

 
—

 
(128,002
)
 
325,410

Derivative instruments associated with offsetting matched book positions
 
—

 
396,163

 
—

 
—

 
396,163

Trade and other payables:
 
 
 
 
 
 
 
 
 


Derivative contracts(5)
 
—

 
21,004

 
—

 
—

 
21,004

Other liabilities
 
—

 
—

 
67

 
—

 
67

Total trade and other payables
 
—

 
21,004

 
67

 
—

 
21,071

Total liabilities at fair value on a recurring basis
 
$
269,913

 
$
600,666

 
$
67

 
$
(128,002
)
 
$
742,644


(1)
We had $1.3 million in transfers of financial instruments from Level 1 to Level 2 during the six months ended March 31, 2016.  These transfers were a result of a decrease in the availability and reliability of the observable inputs utilized in the respective instruments’ fair value measurement. There were no transfers of financial instruments from Level 1 to Level 2 during the three months ended March 31, 2016. We had $300 thousand and $700 thousand in transfers of financial instruments from Level 2 to Level 1 during the three and six months ended March 31, 2016.  These transfers were a result of an increase in the availability and reliability of the observable inputs utilized in the respective instruments’ fair value measurement.  Our policy is that the end of each respective quarterly reporting period determines when transfers of financial instruments between levels are recognized.

(2)
For derivative transactions not cleared through an exchange, and where permitted, we have elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists (see Note 14 for additional information regarding offsetting financial instruments). Deposits associated with derivative transactions cleared through an exchange are included in deposits with clearing organizations on our Condensed Consolidated Statements of Financial Condition.

(3)
The portion of these investments we do not own is approximately $50 million as of March 31, 2016 and are included as a component of noncontrolling interest in our Condensed Consolidated Statements of Financial Condition. The weighted average portion we own is approximately $154 million or 75% of the total private equity investments of $204 million included in our Condensed Consolidated Statements of Financial Condition.

(4)
Other investments include $103 million of financial instruments that are related to obligations to perform under certain deferred compensation plans (see Note 2 on pages 117 - 118, and Note 24 on page 176, of our 2015 Form 10-K for further information regarding these plans).

(5)
Consists of derivatives arising from RJ Bank’s business operations, see Note 13 for additional information.

(6)
Includes the fair value of forward commitments to purchase GNMA or FNMA (as hereinafter defined) MBS arising from our fixed income public finance operations. See Note 2 on page 107, and Note 21 on page 170 of our 2015 Form 10-K, as well as Note 16 in this report, for additional information regarding the GNMA or FNMA MBS commitments.

(7)
Includes individual loans classified as held for sale, which were recorded at a fair value lower than cost.

(8)
Represents the fair value of foreclosed properties which were measured at a fair value subsequent to their initial classification as OREO. The recorded value in the Condensed Consolidated Statements of Financial Condition is net of the estimated selling costs.



September 30, 2015
 
Quoted prices
in active
markets for
identical
assets
(Level 1)
(1)
 
Significant
other
observable
inputs
(Level 2)
(1)
 
Significant
unobservable
inputs
(Level 3)
 
Netting
adjustments
(2)
 
Balance as of
September 30,
2015
 
 
(in thousands)
Assets at fair value on a recurring basis:
 
 
 
 
 
 
 
 
 
 
Trading instruments:
 
 
 
 
 
 
 
 
 
 
Municipal and provincial obligations
 
$
17,318

 
$
188,745

 
$
—

 
$
—

 
$
206,063

Corporate obligations
 
2,254

 
92,907

 
156

 
—

 
95,317

Government and agency obligations
 
7,781

 
108,166

 
—

 
—

 
115,947

Agency MBS and CMOs
 
253

 
117,317

 
—

 
—

 
117,570

Non-agency CMOs and ABS
 
—

 
46,931

 
9

 
—

 
46,940

Total debt securities
 
27,606

 
554,066

 
165

 
—

 
581,837

Derivative contracts
 
—

 
132,707

 
—

 
(90,621
)
 
42,086

Equity securities
 
24,859

 
3,485

 
—

 
—

 
28,344

Brokered certificates of deposit
 
—

 
30,803

 
—

 
—

 
30,803

Other
 
679

 
4,816

 
1,986

 
—

 
7,481

Total trading instruments
 
53,144

 
725,877

 
2,151

 
(90,621
)
 
690,551

Available for sale securities:
 
 

 
 

 
 

 
 

 
 

Agency MBS and CMOs
 
—

 
302,195

 
—

 
—

 
302,195

Non-agency CMOs
 
—

 
71,369

 
—

 
—

 
71,369

Other securities
 
1,402

 
—

 
—

 
—

 
1,402

ARS:
 
 

 
 

 
 

 
 

 


Municipals
 
—

 
—

 
28,015

 
—

 
28,015

Preferred securities
 
—

 
—

 
110,749

 
—

 
110,749

Total available for sale securities
 
1,402

 
373,564

 
138,764

 
—

 
513,730

Private equity investments
 
—

 
—

 
209,088

(3) 
—

 
209,088

Other investments (4)
 
230,839

 
17,347

 
565

 
—

 
248,751

Derivative instruments associated with offsetting matched book positions
 
—

 
389,457

 
—

 
—

 
389,457

Deposits with clearing organizations: (5)
 
 
 
 
 
 
 
 
 
 
Government and agency obligations
 
29,701

 
—

 
—

 
—

 
29,701

Other assets:
 
 
 
 
 
 
 
 
 
 
Derivative contracts (6)
 
—

 
917

 
—

 
—

 
917

Other assets
 
—

 
—

 
4,975

(7) 
—

 
4,975

Total other assets
 
—

 
917

 
4,975

 
—

 
5,892

Total assets at fair value on a recurring basis
 
$
315,086

 
$
1,507,162

 
$
355,543

 
$
(90,621
)
 
$
2,087,170

 
 
 
 
 
 
 
 
 
 
 
Assets at fair value on a nonrecurring basis:
 
 
 
 

 
 

 
 

 
 

Bank loans, net:
 
 
 
 
 
 
 
 
 
 
Impaired loans
 
$
—

 
$
28,082

 
$
37,830

 
$
—

 
$
65,912

Loans held for sale (8)
 
—

 
14,334

 
—

 
—

 
14,334

Total bank loans, net
 
—

 
42,416

 
37,830

 
—

 
80,246

OREO (9)
 
—

 
671

 
—

 
—

 
671

Total assets at fair value on a nonrecurring basis
 
$
—

 
$
43,087

 
$
37,830

 
$
—

 
$
80,917

 
 
 
 
 
 
 
 
 
 
 
(continued on next page)
September 30, 2015
 
Quoted prices
in active
markets for
identical
assets
(Level 1) (1)
 
Significant
other
observable
inputs
(Level 2) (1)
 
Significant
unobservable
inputs
(Level 3)
 
Netting
adjustments (2)
 
Balance as of
September 30,
2015
 
 
(in thousands)
 
 
(continued from previous page)
Liabilities at fair value on a recurring basis:
 
 
 
 

 
 

 
 

 
 

Trading instruments sold but not yet purchased:
 
 
 
 

 
 

 
 

 
 

Municipal and provincial obligations
 
$
17,966

 
$
347

 
$
—

 
$
—

 
$
18,313

Corporate obligations
 
167

 
33,017

 
—

 
—

 
33,184

Government obligations
 
205,658

 
—

 
—

 
—

 
205,658

Agency MBS and CMOs
 
5,007

 
—

 
—

 
—

 
5,007

Total debt securities
 
228,798

 
33,364

 
—

 
—

 
262,162

Derivative contracts
 
—

 
109,120

 
—

 
(88,881
)
 
20,239

Equity securities
 
3,098

 
—

 
—

 
—

 
3,098

Other securities
 
—

 
2,494

 
—

 
—

 
2,494

Total trading instruments sold but not yet purchased
 
231,896

 
144,978

 
—

 
(88,881
)
 
287,993

Derivative instruments associated with offsetting matched book positions
 
—

 
389,457

 
—

 
—

 
389,457

Trade and other payables:
 
 
 
 
 
 
 
 
 
 
Derivative contracts (6)
 
—

 
7,545

 
—

 
—

 
7,545

Other liabilities
 
—

 
—

 
58

 
—

 
58

Total trade and other payables
 
—

 
7,545

 
58

 
—

 
7,603

Total liabilities at fair value on a recurring basis
 
$
231,896

 
$
541,980

 
$
58

 
$
(88,881
)
 
$
685,053


(1)
We had $1.1 million in transfers of financial instruments from Level 1 to Level 2 during the year ended September 30, 2015.  These transfers were a result of a decrease in the availability and reliability of the observable inputs utilized in the respective instruments’ fair value measurement. We had $1.8 million in transfers of financial instruments from Level 2 to Level 1 during the year ended September 30, 2015.  These transfers were a result of an increase in the availability and reliability of the observable inputs utilized in the respective instruments’ fair value measurement.  Our policy is that the end of each respective quarterly reporting period determines when transfers of financial instruments between levels are recognized.

(2)
For derivative transactions not cleared through an exchange, and where permitted, we have elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists (see Note 14 for additional information regarding offsetting financial instruments). Deposits associated with derivative transactions cleared through an exchange are included in deposits with clearing organizations on our Condensed Consolidated Statements of Financial Condition.

(3)
The portion of these investments we do not own is approximately $52 million as of September 30, 2015 and are included as a component of noncontrolling interest in our Condensed Consolidated Statements of Financial Condition. The weighted average portion we own is approximately $157 million or 75% of the total private equity investments of $209 million included in our Condensed Consolidated Statements of Financial Condition.

(4)
Other investments include $106 million of financial instruments that are related to obligations to perform under certain deferred compensation plans (see Note 2 on pages 117 - 118, and Note 24 on page 176, of our 2015 Form 10-K for further information regarding these plans).

(5)
Consists of deposits we provide to clearing organizations or exchanges that are in the form of marketable securities.

(6)
Consists of derivatives arising from RJ Bank’s business operations, see Note 13 for additional information.

(7)
Includes the fair value of forward commitments to purchase GNMA or FNMA (as hereinafter defined) MBS arising from our fixed income public finance operations. See Note 2 on page 107, and Note 21 on page 170 of our 2015 Form 10-K for additional information.

(8)
Includes individual loans classified as held for sale, which were recorded at a fair value lower than cost.

(9)
Represents the fair value of foreclosed properties which were measured at a fair value subsequent to their initial classification as OREO. The recorded value in the Condensed Consolidated Statements of Financial Condition is net of the estimated selling costs
Level 3 Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis, Roll Forward Table of Change in Balances

Additional information about Level 3 assets and liabilities measured at fair value on a recurring basis is presented below:
Three months ended March 31, 2016 Level 3 assets at fair value
(in thousands)
 
Financial assets
 
Financial
liabilities
 
Trading instruments
 
Available for sale securities
 
Private equity, other investments and other assets
 
Payables-
trade and
other
 
Corporate
obligations
 
Non-
agency
CMOs &
ABS
 
Other
 
ARS –
municipals
 
ARS -
preferred
securities
 
Private
equity
investments
 
Other
investments
 
Other
assets
 
Other
liabilities
Fair value
   December 31, 2015
$
189

 
$
9

 
$
1,964

 
$
27,480

 
$
102,899

 
$
207,523

 
$
493

 
$
1,526

 
$
(67
)
Total gains (losses) for the period:
 
 

 
 

 
 

 
 

 
 

 
 
 
 

Included in earnings
(97
)
 
—

 
(100
)
 
133

 
—

 
4,269

 
18

 
1,586

 
—

Included in other comprehensive income
—

 
—

 
—

 
(583
)
 
(300
)
 
—

 
—

 
—

 
—

Purchases and contributions
2

 
—

 
19,470

 
—

 
—

 
2,407

 
—

 
—

 
—

Sales
(94
)
 
—

 
(7,038
)
 
(1,583
)
 
—

 
—

 
—

 
—

 
—

Redemptions by issuer
—

 
—

 
—

 
(25
)
 
—

 
—

 
(5
)
 
—

 
—

Distributions
—

 
(1
)
 
—

 
—

 
—

 
(9,801
)
 
(67
)
 
—

 
—

Transfers: (1)
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 
 
 

Into Level 3
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Out of Level 3
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Fair value
March 31, 2016
$
—

 
$
8

 
$
14,296

 
$
25,422

 
$
102,599

 
$
204,398

 
$
439

 
$
3,112

 
$
(67
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized gains (losses) for the period included in earnings (or changes in net assets) for assets held at the end of the reporting period
$
—

 
$
—

 
$
(60
)
 
$
—

 
$
—

 
$
4,269

 
$
18

 
$
1,586

 
$
—


(1)
Our policy is that the end of each respective quarterly reporting period determines when transfers of financial instruments between levels are recognized.


Six months ended March 31, 2016 Level 3 assets at fair value
(in thousands)
 
Financial assets
 
Financial
liabilities
 
Trading instruments
 
Available for sale securities
 
Private equity, other investments and other assets
 
Payables-
trade and
other
 
Corporate
obligations
 
Non-
agency
CMOs &
ABS
 
Other
 
ARS –
municipals
 
ARS -
preferred
securities
 
Private
equity
investments
 
Other
investments
 
Other
assets
 
Other
liabilities
Fair value
   September 30, 2015
$
156

 
$
9

 
$
1,986

 
$
28,015

 
$
110,749

 
$
209,088

 
$
565

 
$
4,975

 
$
(58
)
Total gains (losses) for the period:
 
 

 
 

 
 

 
 

 
 

 
 
 
 

Included in earnings
(137
)
 
—

 
(349
)
 
133

 
—

 
4,440

 
11

 
(1,863
)
 
—

Included in other comprehensive income
—

 
—

 
—

 
(1,118
)
 
(8,150
)
 
—

 
—

 
—

 
—

Purchases and contributions
75

 
—

 
38,487

 
—

 
—

 
6,961

 
—

 
—

 
(9
)
Sales
(94
)
 
—

 
(25,828
)
 
(1,583
)
 
—

 
(18
)
 
—

 
—

 
—

Redemptions by issuer
—

 
—

 
—

 
(25
)
 
—

 
—

 
(14
)
 
—

 
—

Distributions
—

 
(1
)
 
—

 
—

 
—

 
(16,073
)
 
(123
)
 
—

 
—

Transfers: (1)
 
 
 

 
 

 
 

 
 

 
 

 
 

 
 
 
 

Into Level 3
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Out of Level 3
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Fair value
March 31, 2016
$
—

 
$
8

 
$
14,296

 
$
25,422

 
$
102,599

 
$
204,398

 
$
439

 
$
3,112

 
$
(67
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized gains (losses) for the period included in earnings (or changes in net assets) for assets held at the end of the reporting period
$
(40
)
 
$
1

 
$
(71
)
 
$
—

 
$
—

 
$
4,440

 
$
11

 
$
(1,863
)
 
$
—


(1)
Our policy is that the end of each respective quarterly reporting period determines when transfers of financial instruments between levels are recognized.

Three months ended March 31, 2015 Level 3 assets at fair value
(in thousands)
 
Financial assets
 
Financial
liabilities
 
Trading instruments
 
Available for sale securities
 
Private equity, other investments and other assets
 
Payables-
trade and
other
 
Non-
agency
CMOs &
ABS
 
Equity
securities
 
Other
 
ARS –
municipals
 
ARS -
preferred
securities
 
Private
equity
investments
 
Other
investments
 
Other
assets
 
Other
liabilities
Fair value December 31, 2014
$
11

 
$
14

 
$
5,264

 
$
85,814

 
$
112,955

 
$
208,674

 
$
1,564

 
$
2,407

 
$
(58
)
Total gains (losses) for the period:
 
 
 
 
 
 

 
 

 
 
 
 

Included in earnings
—

 
—

 
(20
)
 
2

 
25

 
14,414

(1) 
41

 
(211
)
 
—

Included in other comprehensive income
—

 
—

 
—

 
3,843

 
(282
)
 
—

 
—

 
—

 
—

Purchases and contributions
—

 
—

 
11,358

 
—

 
—

 
2,241

 
—

 
—

 
—

Sales
—

 
—

 
(15,822
)
 
(45
)
 
—

 
—

 
—

 
—

 
—

Redemptions by issuer
—

 
—

 
—

 
—

 
(250
)
 
—

 
(663
)
 
—

 
—

Distributions
(1
)
 
—

 
—

 
—

 
—

 
(4,385
)
 
(26
)
 
—

 
—

Transfers: (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Into Level 3
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Out of Level 3
—

 
—

 
—

 
—

 
—

 
—


—

 
—

 
—

Fair value
March 31, 2015
$
10

 
$
14

 
$
780

 
$
89,614

 
$
112,448

 
$
220,944

 
$
916

 
$
2,196

 
$
(58
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized gains (losses) for the period included in earnings (or changes in net assets) for assets held at the end of the reporting period
$
—

 
$
—

 
$
—

 
$
—

 
$
—

 
$
14,414

 
$
41

 
$
(211
)
 
$
—


(1)
Primarily results from valuation adjustments of certain private equity investments.  Since we only own a portion of these investments, our share of the net valuation adjustments resulted in a gain of $9.8 million which is included in net income attributable to RJF (after noncontrolling interests).  The noncontrolling interests’ share of the net valuation adjustments was a gain of approximately $4.6 million.

(2)
Our policy is that the end of each respective quarterly reporting period determines when transfers of financial instruments between levels are recognized.


Six months ended March 31, 2015 Level 3 assets at fair value
(in thousands)
 
Financial assets
 
Financial
liabilities
 
Trading instruments
 
Available for sale securities
 
Private equity, other investments and other assets
 
Payables-
trade and
other
 
Non-
agency
CMOs &
ABS
 
Equity
securities
 
Other
 
ARS –
municipals
 
ARS -
preferred
securities
 
Private
equity
investments
 
Other
investments
 
Other
assets
 
Other
liabilities
Fair value September 30, 2014
$
11

 
$
44

 
$
2,309

 
$
86,696

 
$
114,039

 
$
211,666

 
$
1,731

 
$
787

 
$
(58
)
Total gains (losses) for the period:
 
 

 
 

 
 

 
 

 
 
 
 

Included in earnings
—

 
5

 
(40
)
 
2

 
25

 
17,060

(1) 
81

 
1,409

 
—

Included in other comprehensive income
—

 
—

 
—

 
2,961

 
(1,366
)
 
—

 
—

 
—

 
—

Purchases and contributions
—

 
20

 
23,333

 
—

 
—

 
6,343

 
—

 
—

 
—

Sales
—

 
—

 
(24,822
)
 
(45
)
 
—

 
—

 
—

 
—

 
—

Redemptions by issuer
—

 
—

 
—

 
—

 
(250
)
 
—

 
(673
)
 
—

 
—

Distributions
(1
)
 
—

 
—

 
—

 
—

 
(14,125
)
 
(223
)
 
—

 
—

Transfers: (2)
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 
 
 

Into Level 3
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Out of Level 3
—

 
(55
)
 
—

 
—

 
—

 
—

 
—

 
—

 
—

Fair value
March 31, 2015
$
10

 
$
14

 
$
780

 
$
89,614

 
$
112,448

 
$
220,944

 
$
916

 
$
2,196

 
$
(58
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Change in unrealized gains (losses) for the period included in earnings (or changes in net assets) for assets held at the end of the reporting period
$
—

 
$
5

 
$
—

 
$
—

 
$
—

 
$
17,060

 
$
81

 
$
1,409

 
$
—


(1)
Primarily results from valuation adjustments of certain private equity investments.  Since we only own a portion of these investments, our share of the net valuation adjustments resulted in a gain of $12.2 million which is included in net income attributable to RJF (after noncontrolling interests).  The noncontrolling interests’ share of the net valuation adjustments was a gain of approximately $4.9 million.

(2)
Our policy is that the end of each respective quarterly reporting period determines when transfers of financial instruments between levels are recognized.

Gains and Losses (Realized and Unrealized) Included in Revenues

Gains and losses related to Level 3 recurring fair value measurements included in earnings are presented in net trading profit, other revenues and other comprehensive income in our Condensed Consolidated Statements of Income and Comprehensive Income as follows:
 
 
Net trading profit
 
Other revenues
 
Other comprehensive income
 
 
(in thousands)
For the three months ended March 31, 2016
 
 
 
 
 
 
Total (losses) gains included in revenues
 
$
(197
)
 
$
6,006

 
$
—

Change in unrealized (losses) gains for assets held at the end of the reporting period
 
$
(60
)
 
$
5,873

 
$
(883
)
 
 
 
 
 
 
 
For the six months ended March 31, 2016
 
 
 
 
 
 
Total (losses) gains included in revenues
 
$
(486
)
 
$
2,721

 
$
—

Change in unrealized (losses) gains for assets held at the end of the reporting period
 
$
(110
)
 
$
2,588

 
$
(9,268
)
 
 
 
 
 
 
 
For the three months ended March 31, 2015
 
 
 
 
 
 
Total (losses) gains included in revenues
 
$
(20
)
 
$
14,271

 
—

Change in unrealized gains for assets held at the end of the reporting period
 
$
—

 
$
14,244

 
$
3,561

 
 
 
 
 
 
 
For the six months ended March 31, 2015
 
 
 
 
 
 
Total (losses) gains included in revenues
 
$
(35
)
 
$
18,577

 
$
—

Change in unrealized gains for assets held at the end of the reporting period
 
$
5

 
$
18,550

 
$
1,595


Significant Assumptions Used in Valuation of Level 3 Financial Instruments

The significant assumptions used in the valuation of level 3 financial instruments are as follows (the table that follows includes the significant majority of the financial instruments we hold that are classified as level 3 measures):
Level 3 financial instrument
 
Fair value at
March 31,
2016
(in thousands)
 
Valuation technique(s)
 
Unobservable input
 
Range (weighted-average)
Recurring measurements:
 
 
 
 
 
 
 
 
Available for sale securities:
 
 
 
 
 
 
 
 
ARS:
 
 
 
 
 
 
 
 
Municipals - issuer is a municipality
 
$
10,500

 
Discounted cash flow
 
Average discount rate(a)
 
5.37% - 6.61% (5.99%)
 
 
 
 
 
 
Average interest rates applicable to future interest income on the securities(b)
 
1.29% - 2.31% (1.80%)
 
 
 
 
 
 
Prepayment year(c)
 
2018 - 2025 (2022)
Municipals - tax-exempt preferred securities
 
$
14,922

 
Discounted cash flow
 
Average discount rate(a)
 
4.58% - 5.58% (5.08%)
 
 
 

 
 
 
Average interest rates applicable to future interest income on the securities(b)
 
1.07% - 1.07% (1.07%)
 
 
 

 
 
 
Prepayment year(c)
 
2016 - 2021 (2020)
Preferred securities - taxable
 
$
102,599

 
Discounted cash flow
 
Average discount rate(a)
 
4.58% - 6.38% (5.50%)
 
 
 

 
 
 
Average interest rates applicable to future interest income on the securities(b)
 
1.07% - 2.83% (1.50%)
 
 
 

 
 
 
Prepayment year(c)
 
2016 - 2021 (2020)
Private equity investments:
 
$
49,393

 
Income or market approach:
 
 
 
 
 
 
 
 
Scenario 1 - income approach - discounted cash flow
 
Discount rate(a)
 
13% - 21% (17.8%)
 
 
 
 
 
 
Terminal growth rate of cash flows
 
3% - 3% (3%)
 
 
 
 
 
 
Terminal year
 
2017 - 2019 (2018)
 
 
 
 
Scenario 2 - market approach - market multiple method
 
EBITDA Multiple(d)
 
4.75 - 7.5 (6.1)
 
 
 
 
 
 
 Weighting assigned to outcome of scenario 1/scenario 2
 
75%/25%
 
 
$
155,005

 
Transaction price or other investment-specific events(e)
 
Not meaningful(e)
 
Not meaningful(e)
Nonrecurring measurements:
 
 
 
 
 
 
Impaired loans: residential
 
$
22,937

 
Discounted cash flow
 
Prepayment rate
 
7 yrs. - 12 yrs. (10.21 yrs.)
Impaired loans: corporate
 
$
12,783

 
Appraisal or discounted cash flow value(f)
 
Not meaningful(f)
 
Not meaningful(f)

(a)
Represents discount rates used when we have determined that market participants would take these discounts into account when pricing the investments.

(b)
Future interest rates are projected based upon a forward interest rate path, plus a spread over such projected base rate that is applicable to each future period for each security within this portfolio segment.  The interest rates presented represent the average interest rate over all projected periods for securities within the portfolio segment.

(c)
Assumed year of at least a partial redemption of the outstanding security by the issuer.

(d)
Represents amounts used when we have determined that market participants would use such multiples when pricing the investments.

(e)
Certain private equity investments are valued initially at the transaction price until either our annual review, significant transactions occur, new developments become known, or we receive information from the fund manager that allows us to update our proportionate share of net assets, when any of which indicate that a change in the carrying values of these investments is appropriate.

(f)
The valuation techniques used for the impaired corporate loan portfolio are appraisals less selling costs for the collateral dependent loans and discounted cash flows for the remaining impaired loans that are not collateral dependent
Carrying Amounts and Estimated Fair Values of Financial Instruments Not Carried at Fair Value

The estimated fair values by level within the fair value hierarchy and the carrying amounts of our financial instruments that are not carried at fair value are as follows:
 
 
Quoted prices
in active
markets for
identical
assets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total estimated fair value
 
Carrying amount
 
 
(in thousands)
March 31, 2016
 
 
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
 
 
Bank loans, net (1)
 
$
—

 
$
93,926

 
$
14,149,555

 
$
14,243,481

 
$
14,208,236

 
 
 
 
 
 
 
 
 
 
 
Financial liabilities:
 
 
 
 
 
 
 
 

 
 
Bank deposits
 
$
—

 
$
12,380,262

 
$
353,612

 
$
12,733,874

 
$
12,729,457

Other borrowings (2)
 
$
—

 
$
36,549

 
$
—

 
$
36,549

 
$
35,584

Senior notes payable
 
$
367,080

 
$
875,288

 
$
—

 
$
1,242,368

 
$
1,149,316

 
 
 
 
 
 
 
 
 
 
 
September 30, 2015
 
 
 
 
 
 
 
 
 
 
Financial assets:
 
 
 
 
 
 
 
 
 
 
Bank loans, net (1)
 
$
—

 
$
105,199

 
$
12,799,065

 
$
12,904,264

 
$
12,907,776

 
 
 
 
 
 
 
 
 
 
 
Financial liabilities:
 
 
 
 
 
 
 
 

 
 
Bank deposits
 
$
—

 
$
11,564,963

 
$
358,981

 
$
11,923,944

 
$
11,919,881

Other borrowings (2)
 
$
—

 
$
38,455

 
$
—

 
$
38,455

 
$
37,716

Senior notes payable
 
$
368,760

 
$
892,963

 
$
—

 
$
1,261,723

 
$
1,149,222


(1)
Excludes all impaired loans and loans held for sale which have been recorded at fair value in the Condensed Consolidated Statements of Financial Condition at March 31, 2016 and September 30, 2015.

(2)
Excludes the components of other borrowings that are recorded at amounts that approximate their fair value in the Condensed Consolidated Statements of Financial Condition at March 31, 2016 and September 30, 2015.